Abstract

Sociedad Quimica Y Minera De Chile SA will release its quarterly results on May 27, 2026 after market close; this preview outlines the latest market expectations for revenue, profitability, and segment dynamics alongside the dominant institutional stance.

Market Forecast

Consensus points to revenue of 1.63 billion US dollars for the quarter, with forecast year-over-year growth of 56.07%, EBIT of 708.91 million US dollars with 178.11% year-over-year growth, and EPS of 1.56 with 145.31% year-over-year growth; company-level margin guidance is not disclosed, though models imply continued normalization in gross margin and a rebound in net margin. The main business is projected to benefit from improving pricing and volumes in lithium and iodine while specialty plant nutrition remains resilient; the most promising segment is lithium and lithium derivatives with an assumed revenue base of 736.50 million US dollars last quarter and an improving year-over-year trajectory.

Last Quarter Review

Last quarter, revenue was 1.32 billion US dollars, gross profit margin was 33.88%, GAAP net profit attributable to the parent company was 184.00 million US dollars with a net profit margin of 13.88%, and adjusted EPS was 0.65, growing 53.57% year over year. Operating execution stabilized with a 3% quarter-on-quarter increase in net profit, and management delivered better-than-expected top line relative to street models. The main business mix featured lithium and lithium derivatives at 736.50 million US dollars, iodine and derivatives at 271.90 million US dollars, specialty plant nutrition at 250.00 million US dollars, potash at 38.80 million US dollars, industrial chemicals at 18.30 million US dollars, and other products and services at 8.40 million US dollars.

Current Quarter Outlook

Main business momentum

Lithium and lithium derivatives remain the core earnings engine. Forecast revenue expansion to 1.63 billion US dollars overall suggests stronger shipment volumes and selective price recovery in battery-grade material, which, combined with mix benefits from higher-nickel chemistries, can help stabilize unit economics. While gross margin was 33.88% last quarter, the forecast acceleration in EBIT and EPS implies improved operating leverage from cost deflation in feedstock and logistics as well as productivity gains across Chilean assets.

Most promising segment

Lithium and lithium derivatives present the largest upside swing factor given their scale and sensitivity to spot realizations. With a last-quarter revenue base of 736.50 million US dollars, even modest quarter-on-quarter pricing improvement can flow through to EBIT at a high incremental margin, amplifying the forecast 178.11% year-over-year EBIT growth. Contract repricing cadence and customer mix skew toward higher value-added carbonate and hydroxide could further support profitability if spot prices hold steady.

Key stock price drivers this quarter

Share performance this quarter is likely to be driven by realized lithium prices, cost curve positioning in Chile, and the trajectory of inventory normalization at key customers. Price stabilization would validate the sharp EPS rebound forecast to 1.56, while any renewed price weakness could compress margins against rising volumes. Management commentary on capital allocation, production guidance, and contract structures will be closely watched for confirmation of sustainable cash generation through the cycle.

Analyst Opinions

Bullish views dominate recent commentary, with institutions emphasizing a multi-quarter recovery in earnings quality and leverage to a firmer lithium pricing environment. Analysts highlight that the 56.07% revenue growth and 145.31% EPS growth outlook set a constructive bar, supported by anticipated EBIT expansion of 178.11% as operating costs ease and product mix improves; this creates room for upside if pricing surprises positively. Several well-followed sell-side analysts point to accelerating demand from electric vehicles and energy storage as supportive end-markets, noting that Sociedad Quimica Y Minera De Chile SA’s diversified portfolio, including iodine and specialty nutrients, provides an earnings cushion while lithium leads the rebound.